Evaluation of Repetitive Transcranial Magnetic Stimulation on the Pain of Patients with Fibromyalgia

  • Zahra Rezasoltani Associate Professor, Department of Physical Medicine and Rehabilitation, School of Medicine, AJA University of Medical Sciences, Tehran, Iran https://orcid.org/0000-0003-1864-9388
  • Sirous Azizi Assistant Professor, Department of Physical Medicine and Rehabilitation, School of Medicine, AJA University of Medical Sciences, Tehran, Iran https://orcid.org/0000-0002-3251-6322
  • Sharif Najafi Assistant Professor, Department of Physical Medicine and Rehabilitation, School of Medicine, AJA University of Medical Sciences, Tehran, Iran
  • Afsaneh Dadarkhah Instructor, Department of Physical Medicine and Rehabilitation, AJA University of Medical Sciences, Tehran, Iran
  • Sanaz Hamidipanah Resident, Department of Physical Medicine and Rehabilitation , School of Medicine, AJA University of Medical Sciences, Tehran, Iran
  • Masoume Abedi Researcher, Clinical Biomechanical and Rehabilitation Engineering Research Center, AJA University of Medical Sciences, Tehran, Iran
Keywords: Fibromyalgia; Pain; Treatment


Background: Repetitive transcranial magnetic stimulation (rTMS) is amongst the famous reviewed types of noninvasive therapy, newly used to remedy fibromyalgia (FM), a persistent pain disturbance. The aim of this study is to examine the effects of rTMS on the pain of FM in patients.

Methods: A total of 24 patients with FM were recruited and equally divided to randomly receive 4000 pulses at 10 Hz rTMS treatment or sham condition for ten twenty-minute sessions (5 sessions a week over two weeks). Brief Pain Inventory (BPI), FM Impact Questionnaire (FIQ), and McGill Pain Questionnaire (MPQ) were completed before the intervention and after the first, the second, and the fourth weeks of the intervention.

Results: There were no significant differences between groups in terms of sociodemographic variables and clinical characteristics along with analgesic treatments. Analysis indicated that average intensity in patients’ pain was remarkably lower in active group than in the sham one at the second and fourth weeks. Also, McGill affective subscore was considerably lower in active rTMS group than the sham group at the fourth week. Quality of patients’ life at the first, second, and fourth sessions was significantly higher in the active group than in the sham group.

Conclusion: The results of this research showed that excitatory rTMS at prefrontal cortex (PFC) of patients had an effective and long-lasting impact on pain reduction and improvement of patients’ quality of life (QOL).


1. Mease P. Fibromyalgia syndrome: Review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005; 75: 6-21.
2. Mas AJ, Carmona L, Valverde M, Ribas B. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: Results from a nationwide study in Spain. Clin Exp Rheumatol 2008; 26(4): 519-26.
3. Toda K. The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol 2007; 36(2): 140-4.
4. Wolfe F, Hawley DJ, Goldenberg DL, Russell IJ, Buskila D, Neumann L. The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire. J Rheumatol 2000; 27(8): 1989-99.
5. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38(1): 19-28.
6. Marder WD, Meenan RF, Felson DT, Reichlin M, Birnbaum NS, Croft JD, et al. The present and future adequacy of rheumatology manpower. A study of health care needs and physician supply. Arthritis Rheum 1991; 34(10): 1209-17.
7. Crofford LJ, Clauw DJ. Fibromyalgia: Where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum 2002; 46(5): 1136-8.
8. Meeus M, Nijs J. Central sensitization: A biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 2007; 26(4): 465-73.
9. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007; 36(6): 339-56.
10. Jensen KB, Kosek E, Petzke F, Carville S, Fransson P, Marcus H, et al. Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain 2009; 144(1-2): 95-100.
11. Mhalla A, de Andrade DC, Baudic S, Perrot S, Bouhassira D. Alteration of cortical excitability in patients with fibromyalgia. Pain 2010; 149(3): 495-500.
12. Carville SF, Arendt-Nielsen L, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;
67(4): 536-41.
13. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292(19): 2388-95.
14. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 2007; 146(10): 726-34.
15. Williams DA, Gracely RH. Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res Ther 2006; 8(6): 224.
16. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol 2003; 2(3): 145-56.
17. Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. BOLD MRI responses to repetitive TMS over human dorsal premotor cortex. Neuroimage 2005; 28(1): 22-9.
18. Bohning DE, Shastri A, Wassermann EM, Ziemann U, Lorberbaum JP, Nahas Z, et al. BOLD-f MRI response to single-pulse transcranial magnetic stimulation (TMS). J Magn Reson Imaging 2000; 11(6): 569-74.
19. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Wolfe F. Depression and fibromyalgia: Treatment and cost when diagnosed separately or concurrently. J Rheumatol 2004; 31(8): 1621-9.
20. Boonen A, van den Heuvel R, van Tubergen A, Goossens M, Severens JL, van der Heijde D, et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 2005; 64(3): 396-402.
21. Short EB, Borckardt JJ, Anderson BS, Frohman H, Beam W, Reeves ST, et al. Ten sessions of adjunctive left prefrontal rTMS significantly reduces fibromyalgia pain: A randomized, controlled pilot study. Pain 2011; 152(11): 2477-84.
22. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008; 30(11): 1988-2004.
23. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23(2): 129-38.
24. George MS, Wassermann EM. Rapid-rate
transcranial magnetic stimulation and ECT. Convuls Ther 1994; 10(4): 251-4.
25. Paus T, Castro-Alamancos MA, Petrides M. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci 2001; 14(8): 1405-11.
26. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21(15): RC157.
27. Lefaucheur JP, Drouot X, Keravel Y, Nguyen JP. Pain relief induced by repetitive transcranial magnetic stimulation of precentral cortex. Neuroreport 2001; 12(13): 2963-5.
28. Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005; 76(6): 833-8.
29. Fregni F, Gimenes R, Valle AC, Ferreira MJ, Rocha RR, Natalle L, et al. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum 2006; 54(12): 3988-98.
30. Passard A, Attal N, Benadhira R, Brasseur L, Saba G, Sichere P, et al. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Brain 2007; 130(Pt 10): 2661-70.
Original Article(s)